AGL-2263 is an insulin receptor and insulin-like growth factor (IGF) receptor inhibitor.
Storage Temp
Store at -20°C
Shipped In
Ice chest + Ice pads
Product Description
AGL-2263 is an insulin receptor and insulin-like growth factor (IGF) receptor inhibitor
In Vitro
AGL-2263 (5 μM, for 1 h followed by insulin treatment for 24 h) inhibits IR and insulin could still induce phosphorylation of AKT and ERK1/2 after the IR inhibition. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: Granulosa cells. Concentration: 5 μM. Incubation Time: For 1 h followed by insulin treatment for 24 h. Result: Insulin still induced phosphorylation of AKT and ERK1/2 after IR was inhibited by AGL2263.
